Market Overview

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

Share:
Related AKRX
Watch These 8 Huge Call Purchases In Thursday Trade
Benzinga's Option Alert Recap From May 3
Related SLXP
Bill Ackman To Investors: 'Deeply And Profoundly' Sorry For The Valeant Fiasco
BMO Still Believes Valeant Is Undervalued

Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX) is 18.99%. Akorn's revenue for the same period is $227.26 million.

The trailing-twelve-month return on equity at Hi Tech Pharmacal Co (NASDAQ: HITK) is 18.38%. Hi Tech Pharmacal's operating margin for the same period is 24.58%.

The trailing-twelve-month return on equity at Salix Pharmaceuticals (NASDAQ: SLXP) is 15.84%. Salix Pharmaceuticals had $775.90 million in total cash for the latest quarter.

The trailing-twelve-month return on equity at Mylan (NASDAQ: MYL) is 14.65%. Mylan's PEG ratio is 0.72.

Posted-In: Drugs-Generic Industry highest ROE NASDAQTrading Ideas

 

Related Articles (AKRX + HITK)

View Comments and Join the Discussion!